FDA advisory committee set to weigh taking action on certain unapproved peptides

15th April 2026 Uncategorised 0

The FDA’s Pharmacy Compounding Advisory Committee will convene this summer to discuss seven peptides that are currently restricted from use in compounded medications.

More: FDA advisory committee set to weigh taking action on certain unapproved peptides
Source: fierce